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Barcelona, ISGlobal, Barcelona, SpainAbstractDebridement, irrigation and antibiotic treatment form the current approach in early prosthetic joint infection (PJI). Our aim was to design a
score to predict patients with a higher risk of failure. From 1999 to 2014 early PJIs were prospectively collected and retrospectively reviewed.
The primary end-point was early failure deﬁned as: 1) the need for unscheduled surgery, 2) death-related infection within the ﬁrst 60 days
after debridement or 3) the need for suppressive antibiotic treatment. A score was built-up according to the logistic regression coefﬁcients of
variables available before debridement. A total of 222 patients met the inclusion criteria. The most frequently isolated microorganisms were
coagulase-negative staphylococci (95 cases, 42.8%) and Staphylococcus aureus (81 cases, 36.5%). Treatment of 52 (23.4%) cases failed.
Independent predictors of failure were: chronic renal failure (OR 5.92, 95% CI 1.47–23.85), liver cirrhosis (OR 4.46, 95% CI
1.15–17.24), revision surgery (OR 4.34, 95% CI 1.34–14.04) or femoral neck fracture (OR 4.39, 95% CI1.16–16.62) compared with
primary arthroplasty, C reactive protein >11.5 mg/dL (OR 12.308, 95% CI 4.56–33.19), cemented prosthesis (OR 8.71, 95% CI
1.95–38.97) and when all intraoperative cultures were positive (OR 6.30, 95% CI 1.84–21.53). A score for predicting the risk of failure
was designed using preoperative factors (KLIC-score: Kidney, Liver, Index surgery, Cemented prosthesis and C-reactive protein value)
and it ranged between 0 and 9.5 points. Patients with scores of 2, >2–3.5, 4–5, >5–6.5 and 7 had failure rates of 4.5%, 19.4%, 55%,
71.4% and 100%, respectively. The KLIC-score was highly predictive of early failure after debridement. In the future, it would be
necessary to validate our score using cohorts from other institutions.
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E-mail: etornero@clinic.ub.esIntroductionOpen debridement, irrigation with implant retention and anti-
biotic treatment (DAIR) is an accepted approach for earlyMicrobiol Infect 2015; 21: 786.e9–786.e17
nical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infect
p://dx.doi.org/10.1016/j.cmi.2015.04.012prosthetic joint infections (PJI) [1] but the success rate using
this strategy signiﬁcantly varies among different cohorts. Some
authors report failure rates 50% disregarding the causal
microorganism [2–7] whereas others report failure rates
<50%, mainly using rifampin combinations [8–16]. However,
even when using rifampin, success rates are around 55–75%. In
addition, despite the fact that two-stage exchange is associated
with a high success rate, there is evidence showing worse re-
sults when it is performed as a salvage surgical treatment after
failing with debridement and irrigation [17,18]. Therefore, it is
necessary to identify predictors of failure that help surgeons toious Diseases. Published by Elsevier Ltd. All rights reserved
CMI Tornero et al. Score for early PJI treated with DAIR 786.e10select the best initial surgical approach avoiding unnecessary
interventions.
Risk factors for failure in early PJI include infections caused
by Staphylococcus aureus [2,9,11,19,20], arthroscopic debride-
ment [11], polymicrobial infections [15], intra-articular puru-
lence [6], all intraoperative samples being positive [21],
retention of exchangeable components [15], or longer time
between initial arthroplasty and diagnosis [2,3,16]. Some of
these factors are only available after performing debridement
but other reliable markers that are accessible before the ﬁrst
surgical approach are necessary. A previous nomogram using
17 variables was described; however, four variables were
related to aetiological microorganisms that in general are not
available before surgery and they analysed early and late in-
fections [22].
The aim of our study was to identify predictors of early
failure in our 15-year cohort of early PJI managed with
debridement, irrigation and antibiotic treatment and to select
those factors that are widely available before open debridement
so as to design a score that helps us to decide the best initial
surgical approach.Patients and methodsFrom January 1999 to May 2014, all patients with a PJI (hip or
knee arthroplasties) were prospectively registered in a database
and prospectively followed up. For this study PJI diagnosed
within the ﬁrst 90 days after joint arthoplasty and without signs
of loosening of the prosthesis were included. In all cases the
duration of symptoms was shorter than 21 days. PJI was deﬁned
according to Musculoskeletal Infection Society criteria [23].
Variables gathered were: demographics (age and gender), body
mass index (BMI), preoperative American Society of Anesthe-
siologists classiﬁcation, co-morbidity (having or not having one
of the following entities: hypertension, ischaemic heart disease,
heart failure, anticoagulant treatment, diabetes mellitus, malig-
nancy, liver cirrhosis, chronic renal failure, steroid therapy,
dementia, rheumatoid arthritis or chronic obstructive pulmo-
nary disease), site (hip or knee prosthesis), type of surgical
indication (primary or revision surgery or femoral neck frac-
ture), laterality, cemented or non-cemented prosthesis, age of
prosthesis, time between PJI diagnosis and surgical debride-
ment, polyethylene exchange during debridement, the use of
ﬂap for skin coverage, clinical manifestations (having or not
having fever, pain, redness, wound drainage, skin necrosis,
ﬁstulae or septic shock), positive blood cultures, use of anti-
biotic treatment before debridement, baseline (at the moment
of PJI diagnosis) serum analysis including: leucocyte count (cells/
mm3), C-reactive protein (CRP) (mg/dL), creatinine (mg/dL)Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infand glucose (mg/dL), percentage of positive cultures during
debridement (positive cultures from total cultures submitted to
the Microbiology laboratory), isolated microorganisms and
susceptibility pattern, and early outcome. The Ethical Com-
mittee of our institution approved the study.
Deﬁnitions
For the present study the primary end-point was early failure,
which was considered when: 1) the patient needed an un-
scheduled surgery (second debridement or implant removal) to
achieve infection control within the ﬁrst 60 days after initial
debridement; 2) death-related infection within the ﬁrst 60 days
after initial debridement or 3) the need for long-term sup-
pressive antibiotic treatment because the patient’s general
condition contraindicated additional surgeries.
Surgical treatment, microbiology and antibiotic
treatment protocol
In terms of debridement, pre-existing incisions were always
used, necrotic tissue was excised and the joint was washed with
6–9 L of saline. The components were left in situ after con-
ﬁrming that no signs of loosening were present at the time of
surgery. Three to six deep samples of synovial ﬂuid and peri-
prosthetic tissue were submitted to the Microbiology labora-
tory. In addition, blood cultures were performed in patients
with fever at the time of admission for infection. An antibio-
gram for all the isolates was performed by microdilution. After
debridement, a broad-spectrum intravenous antimicrobial
regimen including vancomycin (1 g/12 h) plus ceftazidime (2 g/
8 h) was started and maintained until deﬁnitive microbiological
results were obtained. The protocol of our hospital recom-
mends 10 days of intravenous antibiotics and afterwards to
switch to oral bioﬁlm-active antibiotics. The duration of oral
antibiotics was not standardized and it was decided by a
member of the team (A.S.) based on the clinical manifestations
of each case and the CRP concentration during follow up;
however, all patients received at least 6 weeks. After being
discharged, patients were followed up monthly while they were
receiving antibiotic treatment and every 3–6 months during the
ﬁrst year after ﬁnishing therapy and once per year afterwards.
Statistical analysis
Continuous variables were expressed as mean and standard
deviation (SD) or median and interquartile range (IQR) and
were compared using the Student’s t test or the Mann–
Whitney U test according to the Kolmogorov–Smirnov test of
normality. Continuous variables were also categorized ac-
cording to the 75th centile (age of prosthesis until debridement
30 days and >30 days, time between PJI diagnosis and surgical
debridement 4 days and >4 days, preoperative leucocyte
ectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 786.e9–786.e17
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CRP 11.5 mg/dL and >11.5 mg/dL, preoperative creatinine
1.1 mg/dL and >1.1 mg/dL and preoperative glucose 125
mg/dL and >125 mg/dL), except for BMI value, which was
categorized according to the WHO’s obesity classiﬁcation (<35
kg/m2 and 35 kg/m2), and patient age, which was categorized
according to the mean value (<70 years and 70 years).
Qualitative variables were described by absolute frequencies
and percentages and were compared using the chi-square test
or Fisher’s exact test when necessary. Correlation curves be-
tween continuous variables were estimated by testing linear,
logarithmic, exponential and quadratic equation models. The
Kaplan–Meier survival method was used to estimate the cu-
mulative probability of treatment success of the whole cohort
from debridement and log-rank test was applied to compare
survival curves. A forward stepwise logistic regression model
was performed to identify independent predictors of failure.
Goodness of ﬁt was explored based on the Hosmer–
Lemeshow test. Based on the logistic regression ﬁndings, a
predictive additive scoring tool was developed to identify pre-
operative clinical signs of failure. Coefﬁcients from the logistic
regression were converted to intervals of 0.5. Risk groups were
deﬁned by the inspection of the prevalence of failure given the
different score values. The predictive value of the scoring tool
was checked for correctly indicating the failure rate via a
receiver-operating characteristic curve. Statistical signiﬁcance
was deﬁned as a two-tailed p < 0.05. The analysis was per-
formed using SPSS, version 20.0 (SPSS, Inc., Chicago, IL, USA).ResultsA total of 222 patients with early PJI met the inclusion criteria
for the study. The mean (SD) age of cohort was 71.6 (10.7)
years and 121 were female (54.5%). One hundred and thirty-
seven (61.7%) infections were of knee prostheses and in 165
(74.3%) patients the infected arthroplasty was cemented. In 34
(15.3%) patients the indication of the infected prosthesis was a
femoral neck fracture and in 42 (18.9%) the PJI was on a
revision arthroplasty. The infection was polymicrobial in 85
(38.3%) patients and the most frequently isolated microorgan-
isms were coagulase-negative staphylococci (95 cases, 42.8%),
S. aureus (81 cases, 36.5%), Escherichia coli (30 cases, 13.5%),
Enterococcus spp. (29 cases, 13.1%), Pseudomonas aeruginosa (22
cases, 9.9%) and Enterobacter cloacae (15 cases, 6.8%). Fifty-two
(23.4%) patients failed within the ﬁrst 60 days after ﬁrst
debridement. The main characteristics of the cohort according
to the outcome are shown in Table 1. Heart failure (44.1%
versus 19.6%, p 0.002), chronic renal failure (60.0% versus
19.8%, p < 0.001) and liver cirrhosis (47.8% versus 20.6%, pClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infect0.004) were signiﬁcantly associated with failure. Primary pros-
thesis had a lower failure rate (19.7%) than revision arthro-
plasties (38.1%) and prosthesis indicated for femoral neck
fracture (35.2%, p 0.003). Patients with bacteraemia (54.5%
versus 21.8%, p 0.022), CRP >11.5 mg/dL (56.0% versus 15.6%,
p < 0.001), leucocyte count >10 000 cell/mm3 (35.4% versus
18.6%, p 0.007) and creatinine >1.1 mg/dL (33.9% versus 20.4%,
p = 0.038) had a signiﬁcantly higher failure rate. When all
intraoperative cultures were positive (32.6% versus 9.4%
p < 0.001) or PJI was polymicrobial (28.2% versus 20.4%,
p = 0.182) there was a higher failure rate whereas mono-
microbial PJI due to coagulase-negative staphylococci presented
a signiﬁcantly lower failure rate (12.5% versus 26.4%, p 0.044).
Values of CRP were carefully evaluated as a predictor of
bacterial inoculum and treatment failure. CRP showed a direct
relationship with the percentage of positive cultures (Fig. 1,
linear equation, R2 = 0.046, p 0.002) and an inverse association
with the time between the debridement and failure (Fig. 2,
logarithmic equation, R2 = 0.179, p 0.003). Fig. 3 shows the
cumulative survival function within the ﬁrst 2 months after
debridement according to the CRP value (log-rank test,
p < 0.001).
All variables studied in the univariate analysis were included
in a multivariate analysis except those with 10% of missing
data (BMI, American Society of Anesthesiologists classiﬁcation
and antibiotic treatment before surgery). The step-wise for-
ward logistic regression model identiﬁed as independent pre-
dictors of failure: chronic renal failure (OR 5.92, 95% CI
1.47–23.85), liver cirrhosis (OR 4.46, 95% CI 1.15–17.24),
revision surgery (OR 4.34, 95% CI 1.34–14.04) or femoral neck
fracture (OR 4.39, 95% CI 1.16–16.62) compared with primary
arthroplasty, CRP >11.5 mg/dL (OR 12.308, 95% CI
4.56–33.19), cemented prosthesis (OR 8.71, 95% CI
1.95–38.97) and when all intraoperative cultures were positive
(OR 6.30, 95% CI 1.84–21.53) (Hosmer–Lemeshow test, p
0.839).
A score for predicting the risk of failure was designed
(Table 2) including all preoperative factors identiﬁed as inde-
pendent predictors of failure (KLIC-score: Kidney, Liver, Index
surgery, Cemented prosthesis and C-reactive protein value).
The scores ranged from 0 to 9.5. By checking the score, pa-
tients were divided into ﬁve groups according to their overall
score (Fig. 4). Among patients with a score 2, the failure rate
was 4.5%, compared with 19.4% in those with >2 to 3.5 points,
55% in those with 4–5 points, 71.4% in those with >5 to 6.5
points and 100% when the score was 7 points. Fig. 5 shows
the receiver-operating characteristic curve and the area under
the receiver-operating characteristic curve was 0.839 (95% CI
0.767–0.911). A score >3.5 was associated with the best bal-
ance between sensitivity (0.739) and speciﬁcity (0.861).ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 786.e9–786.e17
TABLE 1. Characteristics of patients according to the outcome
Characteristics Remission (n [ 170) Failure (n [ 52) p
Mean age (SD) years 71.3 (10.4) 72.4 (11.6) 0.545
Age 70 years 102 (60.0) 33 (63.5) 0.655
Gender
Male 76 (44.7) 25 (48.1) 0.669
Female 94 (55.3) 27 (51.9)
Mean (SD) BMI (kg/m2) 31.1 (6.0) 31.6 (5.4) 0.672
BMI 35 (kg/m2) 32 (22.4) 7 (19.4) 0.703
Preoperative ASA Classiﬁcation III– IV 45 (30.4) 18 (46.2) 0.064
Co-morbidities
Hypertension 116 (68.2) 35 (67.3) 0.900
Ischaemic heart disease 19 (11.2) 7 (13.5) 0.654
Heart failure 19 (11.2) 15 (28.8) 0.002
Anticoagulant 10 (5.9) 6 (11.5) 0.217
Diabetes mellitus 31 (18.2) 8 (15.4) 0.636
Malignancy 22 (12.9) 5 (9.6) 0.521
Chronic obstructive pulmonary disease 27 (15.9) 7 (13.5) 0.671
Chronic renal failure 8 (4.7) 12 (23.1) <0.001
Liver cirrhosis 12 (7.1) 11 (21.2) 0.004
Steroid therapy 16 (9.4) 9 (17.3) 0.115
Dementia 7 (4.1) 5 (9.6) 0.158
Rheumatoid arthritis 5 (2.9) 3 (5.8) 0.394
Indication for previous surgery
Primary surgery 122 (71.8) 24 (46.2) 0.003
Revision surgery 26 (15.3) 16 (30.8)
Hip fracture 22 (12.9) 12 (23.1)
Laterality (Right) 82 (48.2) 31 (59.6) 0.151
Type of cementation
Not cemented 46 (27.1) 11 (21.2) 0.394
Cemented 124 (72.9) 41 (78.8)
Site of arthroplasty
Hip 61 (35.9) 24 (46.2) 0.195
Knee 109 (64.1) 28 (53.8)
Median (IQR) age of prosthesis (days) until debridement 23 [16;31] 21 [14;29.75] 0.146
Age of prosthesis >30 days 43 (25.3) 12 (23.1) 0.855
Median (IQR) days between diagnosis and debridement 2 [1;4] 2 [1;4] 0.810
Days between diagnosis and debridement >4 37 (22.8) 11 (23.4) 0.935
Polyethylene exchange during debridement 122 (73.1) 37 (72.5) 0.943
Need ﬂap for skin coverage 6 (3.5) 4 (7.7) 0.249
Clinical signs
Fever 34 (20.0) 15 (30.0) 0.135
Pain 57 (69.5) 19 (73.1) 0.729
Redness 74 (89.2) 24 (92.3) 1.000
Wound drainage 82 (82.8) 23 (76.7) 0.447
Skin necrosis 9 (10.0) 4 (14.3) 0.505
Presence of ﬁstula 12 (14.1) 5 (17.9) 0.761
Bacteraemia 5 (2.9) 6 (11.5) 0.022
Septic shock 0 (0) 1 (1.9) 0.234
Antibiotic treatment prior debridement 22 (25.9) 6 (25.0) 0.930
Median (IQR) leucocyte count (cell/mm3) 8400 [6600;9980] 9250 [7000;12670] 0.068
Leucocyte count >10 000 cell/mm3 42 (24.9) 23 (44.2) 0.007
Median (IQR) CRP (mg/dL) 3.05 [1.51;7.03] 14.77 [4.72;23.41] <0.001
CRP >11.5 mg/dL 22 (13.9) 28 (60.9) <0.001
Median (IQR) creatinine 0.84 [0.70;1.08] 0.90 [0.80;1.30] 0.003
Creatinine >1.1 mg/dL 37 (22.2) 19 (36.5) 0.038
Median (IQR) glycaemia 105 [95;126.5] 111.5 [98.25;129] 0.181
Glycaemia >125 mg/dL 42 (25.5) 17 (32.7) 0.306
Median (IQR) percentage of positive cultures 100 [67;100] 100 [100;100] <0.001
All cultures positive during debridement 91 (53.8) 44 (86.3) <0.001
Polymicrobial infection 61 (35.9) 24 (46.2) 0.182
Presence of microorganism
Staphylococcus aureus 60 (35.3) 21 (40.4) 0.514
Methicillin-resistant 11 (6.5) 4 (7.7) 0.756
Methicillin-sensitive 49 (28.8) 17 (32.7) 0.606
Coagulase-negative staphylococci 80 (47.1) 15 (28.8) 0.020
Methicillin-resistant 46 (27.1) 9 (17.3) 0.154
Methicillin-sensitive 17 (10.0) 1 (1.9) 0.080
Unknown methicillin resistance 17 (10.0) 5 (9.6) 0.935
Enterococcus spp. 19 (11.2) 10 (19.2) 0.132
Streptococcus spp. 6 (3.5) 1 (1.9) 1.000
Escherichia coli 20 (11.8) 10 (19.2) 0.168
Pseudomonas spp. 16 (9.4) 6 (11.5) 0.653
Enterobacter cloacae 11 (6.5) 4 (7.7) 0.759
Proteus spp. 12 (7.1) 3 (5.8) 1.000
Bold indicates statistically signiﬁcant differences.
ASA, American Society of Anesthesiologists; BMI, body mass index; COPD, chronic obstructive pulmonary disease; CRP, C-reactive protein; IQR, interquartile range.
CMI Tornero et al. Score for early PJI treated with DAIR 786.e12DiscussionThe primary goal of debridement and irrigation is to achieve
infection control with only one surgical intervention. Indeed, aClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infrecent article comparing one versus three consecutive de-
bridements has demonstrated a worse outcome in the second
arm mainly as the result of a higher re-infection rate [24]. This
result suggests that every time the prosthesis is opened, there is
a risk of contamination by different microorganisms and as aectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 786.e9–786.e17
FIG. 1. Linear correlation between
preoperative C-reactive protein value
(mg/dL) and percentage of positive cul-
tures obtained during debridement.
786.e13 Clinical Microbiology and Infection, Volume 21 Number 8, August 2015 CMIresult the majority of these patients require a two-stage ex-
change to control the infection. Although two-stage exchange is
associated with a high success rate, when it is performed as a
salvage option after failed debridement the rate of success is
signiﬁcantly lower [17,18]. Based on these facts, it is necessary
to identify not only robust predictors of failure but also those
that are available early in the course of the infection. This is
particularly important in early PJI because in these infections
the longer the time to debridement the higher the failure rate
[2,3,16].
Our results from a large single-centre cohort with a standard
protocol for the management of early PJI throughout the lastClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infect15 years identiﬁed that when all cultures obtained during
debridement are positive there is a high risk of failure (OR 6.30)
as was also identiﬁed by Bouaziz et al. [21]. This supports the
association of high bacterial inoculum with a more severe
infection and a higher risk for early failure, as has been also
demonstrated in patients with pneumonia [25]. A high bacterial
inoculum signiﬁcantly reduces the efﬁcacy (‘inoculum effect’) of
β-lactams [26] and glycopeptides [27,28]. In addition, it has
been recently shown that S. aureus in synovial ﬂuid forms
clumps that are deposited on the inner surface of the synovial
membrane and show a resistant pattern similar to the one
described in bioﬁlms [29]. It is reasonable to assume that theFIG. 2. Logarithmic correlation curve
between preoperative C-reactive protein
value and time between debridement and
failure.
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 786.e9–786.e17
FIG. 3. Cumulative survival function
within the ﬁrst 2 months after debride-
ment according to the C-reactive protein
concentration (11.5 or >11.5 mg/dL).
CMI Tornero et al. Score for early PJI treated with DAIR 786.e14higher the inoculum the higher the number of bacterial clumps,
making the activity of antibiotics difﬁcult. For this reason, it is
necessary to identify preoperative predictors of bacterial
inoculum. In line with this, CRP is a cheap and widely available
acute-phase protein synthesized by the liver in response to
factors released by macrophages. CRP binds to the bacterial
surface and activates the complement system, promoting
phagocytosis by macrophages, which clears bacteria. In our
study, CRP showed a direct relationship with the percentage of
positive cultures and an inverse correlation with the time from
debridement to failure (Figs. 1 and 2), suggesting that it is a good
surrogate marker for the bacterial inoculum. Another charac-
teristic of our series is the high rate of polymicrobial infections
(38%); however, it was similar to the rate reported by others in
patients with similar characteristics [30,31].
Considering those predictors available before surgery like
chronic renal failure, liver cirrhosis, cemented prosthesis,
revision arthroplasty or arthroplasty for femoral neck fractureTABLE 2. KLIC-score (Kidney, Liver, Index surgery,
Cemented prosthesis and C-reactive protein value): scoring
system to evaluate the early failure rate of prosthetic joint
infections treated with debridement, irrigation and implant
retention
Variable Score
K Chronic renal failure (Kidney) 2
L Liver cirrhosis 1.5
I Index surgery = Revision surgery or prosthesis
indicated for femoral neck fracture
1.5
C Cemented prosthesis 2
C C-reactive protein >11.5 mg/dL 2.5
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infand CRP, a useful score (Table 2) to identify patients at a higher
risk of failure was built-up (Fig. 4). According to the KLIC-
score, patients with 4 points had a failure rate >60% and
should be considered for alternative strategies different from
standard debridement and irrigation. The potential alternatives
could be: 1) multiple scheduled debridements; however, recent
experience [24] demonstrated that this strategy is worse than
only one debridement, 2) removing the prosthesis as a ﬁrst
surgical approach (one- or two-stage exchange); however,
other authors did not ﬁnd differences between DAIR and
prosthesis exchange in early PJI [31,32], and 3) to start with
more potent anti-bioﬁlm antibiotics than vancomycin or even
to locally administer high antibiotic concentrations. A recent
multi-centric study evaluated the efﬁcacy of high-dose dapto-
mycin plus rifampin as initial treatment in 18 early PJIs due to
ﬂuoroquinolone-resistant staphylococci [33]. The overall failure
rate was 50% and the relapse rate was 28%, which was better
than the rates reported with vancomycin [4]. As prosthesis
exchange is an aggressive surgical approach for implants that are
not loosened, we consider that efforts should be focused on
improving the success rate of DAIR, perhaps using additional
strategies such as more potent systemic antibiotics or the
administration of local antibiotics.
There are some limitations to our study; ﬁrst, our score was
obtained from a single-centre experience; therefore, we cannot
be sure about its applicability in other centres. Second, other
biomarkers such as procalcitonin or interleukin-6 could be
more accurate than CRP; however, these parameters are not
available everywhere whereas CRP is a cheap and widely used
marker. Third, although a follow-up of 2 years is, in general,
required to evaluate the outcome of PJIs, the aim of our study
was to identify predictors of early failure (within the ﬁrstectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 786.e9–786.e17
FIG. 5. Receiver-operating characteristic
curve of the KLIC-score.
FIG. 4. Percentage of remission and
failure after debridement according to
the stratiﬁcation derived from the KLIC-
score.
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CMI Tornero et al. Score for early PJI treated with DAIR 786.e1660 days) that lead to additional and unscheduled surgery
because late failure could be inﬂuenced by many other factors.
Finally, our study included only early (<3 months) PJI; therefore,
the KLIC-score could not be applied for predicting the
outcome of late acute haematogenous PJI.
In conclusion, the early failure rate with debridement and
irrigation in a large single-centre cohort was 23.4% and the
main predictors of failure were co-morbidity, the reason for
arthroplasty, cemented or non-cemented prosthesis, the
baseline CRP and the number of positive intra-operative cul-
tures. Considering only those factors available before the ﬁrst
surgical approach, a useful score was designed with a high
predictive value. In the future, it would be necessary to validate
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